Education
About Us
Working with TipRanks
Follow Us
Dicot Pharma AB (SE:DICOT)
:DICOT
DICOT Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.15 - kr0.90
Previous CloseN/A
Volume3.90M
Average Volume (3M)21.29M
Market Cap
kr1.28B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Aug 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding2,009,342,500
10 Day Avg. Volume10,177,205
30 Day Avg. Volume21,285,678
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DICOT FAQ
What was Dicot Pharma AB’s price range in the past 12 months?
Dicot Pharma AB lowest stock price was kr0.15 and its highest was kr0.90 in the past 12 months.
What is Dicot Pharma AB’s market cap?
Dicot Pharma AB’s market cap is kr1.28B.
When is Dicot Pharma AB’s upcoming earnings report date?
Dicot Pharma AB’s upcoming earnings report date is Aug 11, 2025 which is in 44 days.
How were Dicot Pharma AB’s earnings last quarter?
Dicot Pharma AB released its earnings results on Apr 29, 2025. The company reported -kr0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.013.
Is Dicot Pharma AB overvalued?
According to Wall Street analysts Dicot Pharma AB’s price is currently Overvalued.
Does Dicot Pharma AB pay dividends?
Dicot Pharma AB does not currently pay dividends.
What is Dicot Pharma AB’s EPS estimate?
Dicot Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dicot Pharma AB have?
Dicot Pharma AB has 2,009,342,500 shares outstanding.
What happened to Dicot Pharma AB’s price movement after its last earnings report?
Dicot Pharma AB reported an EPS of -kr0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.941%.
Which hedge fund is a major shareholder of Dicot Pharma AB?
Currently, no hedge funds are holding shares in SE:DICOT
Technical Analysis
Vicore Pharma Holding AB
―
Elicera Therapeutics AB
―
Ascelia Pharma AB
―
IRLAB Therapeutics AB Class A
―
Xspray Pharma AB
―